Apigenin binds to the benzodiazepine site on GABA-A receptors, but as a partial agonist rather than the full agonist that drugs like Xanax are. This means it calms without the heavy sedation, memory impairment, or addiction potential. It also inhibits CD38 — an enzyme that degrades NAD+ — which is why it appears in longevity stacks alongside NMN or NR. The dual GABA + NAD+ mechanism makes it uniquely positioned at the intersection of sleep and aging science.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.